Propofol Spinal Procedural Sedation for Cesarean Section

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 10, 2018

Study Completion Date

September 10, 2018

Conditions
Patient Compliance
Interventions
DRUG

propofol

A bolus of 0.7 mg/kg will be given initially, additional incremental doses of 20 mg propofol will be given if the patient complained of pain or moved arms towards the back. Patients will be sitting on the middle of the operating table facing towards the table's foot. The table's foot will be dropped 45 degrees for a comfortable chair position, Monitoring through pulse oximeter (SaO2), non-invasive blood pressure (NIBP) adjusted every 2 minutes automatic measuring and capnography tube in contact with nostrils.

Trial Locations (3)

35516

Delta Hospital, Al Mansurah

Mansoura University Hospital, Al Mansurah

44519

Zagazig University Hospital, Zagazig

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03437980 - Propofol Spinal Procedural Sedation for Cesarean Section | Biotech Hunter | Biotech Hunter